Preview

Стационарозамещающие технологии: Амбулаторная хирургия

Расширенный поиск

Возможности применения сульфатиазола серебра для местного лечения раневой инфекции

https://doi.org/10.21518/1995-14772018-1-2-42-51

Полный текст:

Аннотация

В данной статье рассмотрены преимущества и недостатки применения препаратов на основе соединений серебра для местного лечения раневых инфекций. На основании данных сравнительных клинических исследований показаны преимущества локальных препаратов серебра при воздействии на раневой процесс. Описаны преимущества сульфатиазола серебра в качестве топического агента при местном лечении раневых инфекций.

Об авторах

А. В. Родин
Смоленский государственный медицинский университет
Россия


В. В. Привольнев
Смоленский государственный медицинский университет
Россия


А. Н. Барсуков
Смоленский государственный медицинский университет
Россия


Список литературы

1. Логинов В.И., Паршиков В.В., Касимов Р.Р., Бабурин А.Б. Современные механические способы интраоперационной профилактики инфекций области хирургического вмешательства. Новости хирургии, 2015, 23(5): 559-565./ Loginov VI, Parshikov VV, Kasimov RR, Baburin AB. Modern mechanical methods for intraoperative prevention of infections as pertaining to surgical intervention. Novosti Khirurgii, 2015, 23 (5): 559-565.

2. Привольнев В.В., Пасхалова Ю.С., Родин А.В., Митиш В.А. Местное лечение ран и раневой инфекции по результатам анонимного анкетирования хирургов России. Раны и раневые инфекции, 2016, 1: 19-24. Privolnev VV, Paskhalova Yu.S., Rodin AV, Mitish VA. Topical treatment of wounds and wound infection based on the results of anonymous questioning of Russian surgeons. Rany i Ranevye Infektsii, 2016, 1: 19-24.

3. Привольнев В.В., Родин А.В., Федоров Р.Э., Хвостов Д.Л. Перспективы использования местной антибиотикотерапии в лечении остеомиелита. Врач, 2016, 11: 12-16. /Privolnev VV, Rodin AV, Fedorov RE, Khvostov DL. Prospects for using topical antibiotic therapy for treatment of osteomyelitis. Vrach, 2016, 11: 12-16

4. Dissemond J, Bottrich JG, Braunwarth H, Hilt J, Wilken P, Munter KC. Evidence for silver in wound care - meta-anal-ysis of clinical studies from 2000-2015. J Dtsch Dermatol Ges, 2018, 15(5): 524-535.

5. Букина Ю.А., Сергеева Е.А. Антибактериальные свойства и механизм бактерицидного действия наночастиц и ионов серебра. Вестник Казанского технологического университета, 2012, 15(14): 170-172./ Bukina YuA., Sergeeva EA. Antibacterial properties and bactericidal mechanism of nanoparticles and silver ions. Vestnik Kazanskogo Tehnologicheskogo Universiteta, 2012, 15 (14): 170-172.

6. Dibrov P, Dzioba J, Gosink KK, Hase CC. Chemiosmotic mechanism of antimicrobial activity of Ag+ in Vibrio cholera. Antimicrobial Agents and Chemotherapy, 2002, 46: 2668-2670.

7. Kim JS, Kuk E, Yu KN, Kim JH, Park SJ, Lee HJ et al. Antimicrobial effects of silver nanoparticles. Nanomedicine, 2007, 3(1): 95-101.

8. Morones JR, Elechiguerra JL, Camacho A, Holt K, Kouri JB, Ramfrez JT et al. The bactericidal effect of silver nanoparticles. Nanotechnology, 2005, 16(10): 2346-2353.

9. Nagy A, Harrison A, Sabbani S, Munson RS Jr, Dutta PK, Waldman WJ. Silver nanoparticles embedded in zeolite membranes: release of silver ions and mechanism of antibacterial action. Int J Nanomedicine, 2011, 6: 1833-1852.

10. Bhol KC, Schechter PJ. Topical nanocrystalline silver cream suppresses inflammatory cytokines and induces apoptosis of inflammatory cells in a murine model of allergic contact dermatitis. The British Journal of Dermatology, 2005, 152: 1235-1242.

11. Nadworny PL, Wang J, Tredget EE, Burrell RE.Anti-inflammatory activity of nanocrystalline silver-derived solutions in porcine contact dermatitis. J Inflamm (Lond), 2010, 7: 13.

12. Aparna Mani KM, Seethalakshmi S, Gopal V. Evaluation of in-vitro anti-inflammatory activity of silver nanoparticles synthesised using piper nigrum extract. Journal of Nanomedicine & Nanotechnology, 2015, 6: 2.

13. Dasgupta N, Ranjan S, Rajendran B, Manickam V, Ramalingam C, Avadhani GS et al. Thermal co-reduction approach to vary size of silver nanoparticle: its microbial and cellular toxicology. Environ Sci Pollut Res Int, 2016, 23(5): 4149-4163.

14. Kim KJ, Sung WS, Suh BK, Moon SK, Choi JS, Kim JG et al. Antifungal activity and mode of action of silver nanoparticles on Candida albicans. Biometals, 2009, 22(2): 235242.

15. Lu L, Sun RW, Chen R, Hui CK, Ho CM, Luk JM et al. Silver nanoparticles inhibit hepatitis B virus replication. Antivir Ther, 2008, 13(2): 253-262.

16. Gupta A, Matsui K, Lo JF, Silver S. Molecular basis for resistance to silver cations in Salmonella. Nature Medicine, 1999, 5: 183-188.

17. Sutterlin S, Dahlo M, Tellgren-Roth C, Schaal W, Melhus A. High frequency of silver resistance genes in invasive isolates of Enterobacter and Klebsiella species. J Hosp Infect, 2018, 96(3): 256-261.

18. McCague A, Joe VC. A case of argyria and acuteleukopenia associated with the use of an antimicrobial soft silicone foam dressing. J Burn Care Res, 2016, 37(5): e493-e496.

19. Wang XQ, Chang HE, Francis R, Olszowy H, Liu PY, Kempf M et al. Silver deposits in cutaneous burn scar tissue is a common phenomenon following application of a silver dressing. J Cutan Pathol, 2009, 36: 788-792.

20. Zou SB, Yoon WY, Han SK, Jeong SH, Cui ZJ, Kim WK. Cytotoxicity of silver dressings on diabetic fibroblasts. Int Wound J, 2013, 10(3): 306-312.

21. Karlsmark T, Agerslev RH, Bendz SH, Larsen JR, Roed-Petersen J, Andersen KE. Clinical performance of a new silver dressing, Contreet Foam, for chronic exuding venous leg ulcers. Journal of wound care, 2003, 12(9): 351-354.

22. Chuangsuwanich A, Charnsanti 0, Lohsiriwat V, Kangwanpoom C, Thong-In N et al. The efficacy of silver mesh dressing compared with silver sulfadiazine cream for the treatment of pressure ulcers. J Med Assoc Thai, 2011, 94: 559-565.

23. Jude EB, Apelqvist J, Spraul M, Martini J; Silver Dressing Study Group. Prospective randomized controlled study of hydrofiber dressing containing ionic silver or calcium alginate dressings in non-ischaemic diabetic foot ulcers. Diabet Med, 2007, 24 : 28 0-288.

24. Russell L. The C0NT0P multinational study: preliminary data from the UK arm. Wounds UK, 2005, 1: 44-54.

25. Verdu Soriano J, Rueda Lopez J, Martfnez Cuervo F, Soldevilla Agreda J. Effects of an activated charcoal silver dressing on chronic wounds with no clinical signs of infection. J Wound Care, 2004, 13(419): 421-423.

26. Beele H, Meuleneire F, Nahuys M, Percival SL. A prospective randomised openlabel study to evaluate the potential of a new silver alginate/carboxymethylcellulose antimicrobial wound dressing to promote wound healing. Int Wound J, 2010, 7: 262-270.

27. Jorgensen B, Price P, Andersen KE, Gottrup F, Bech-Thomsen N, Scanlon E et al. The silver-releasing foam dressing, Contreet Foam, promotes faster healing of critically colonised venousleg ulcers: a randomised, controlled trial. Int Wound J, 2005, 2: 64-73.

28. Meaume S, Vallet D, Morere MN, Teot L. Evaluation of a silverreleasing hydroalginate dressing in chronic wounds with signs oflocal infection. J Wound Care, 2005, 14: 411419.

29. Eberlein T, Haemmerle G, Signer M, Gruber Moesenbacher U, Traber J, Mittlboeck M et al. Comparison of PHMB-containing dressing and silver dressings in patients with critically colonised orlocally infected wounds. J Wound Care, 2012, 21: 12-20.

30. SiegeL HJ, Herrera DF, Gay J. Silver negative pressure dressing with vacuum-assisted closure of massive pelvic and extremity wounds. Clin Orthop Relat Res, 2014, 472: 830-835.

31. Krieger BR, Davis DM, Sanchez JE, Mateka JJ, Nfonsam VN, Frattini JC et al. The use of silver nylon in preventing surgical site infections following colon and rectal surgery. Dis Colon Rectum, 2011, 54: 1014-1019.

32. Siah CJ, Yatim J. Efficacy of a total occlusive ionic sil-vercontaining dressing combination in decreasing risk of surgical site infection: an RCT. J Wound Care, 2011, 20: 561-568.

33. Bailey S, Carmean M, Cinat M, Burton K, Lane C, Malinoski D et al. A randomized comparison study of Aquacel Ag and Glucan II as donor site dressings with regard to healing time, cosmesis, infection rate, and patient's perceived pain: a pilot study. J Burn Care Res, 2011, 32: 627-632.

34. Lohsiriwat V, Chuangsuwanich A. Comparison of the ionic silver-containing hydrofiber and paraffin gauze dressing on split-thickness skin graft donor sites. Ann Plast Surg, 2009, 62: 421-422.

35. Jurczak F, Dugre T, Johnstone A, Offori T, Vujovic Z, Hollander D; AQUACEL Ag Surgical/Trauma Wound Study Group. Randomised clinical trial of Hydrofiber dressing with silver versus povidone-iodine gauze in the management of open surgical and traumatic wounds. Int Wound J, 2007, 4: 66-76.

36. Fox CL Jr, Modak SM. Mechanism of silver sulfadiazine action on burn wound infections. Antimicrob Agents Chemother, 1974, 5(6): 582-588.

37. Самцов А.В., Теличко И.Н., Стаценко А.В., Хайрутдинов В.Р. Применение наружных средств, содержащих соединения серебра, в терапии больных пиодермиями. Вестник дерматологии и венерологии, 2014, 1: 75-80. / Samtsov AV, Telichko IN, Statsenko AV, Khayrutdinov VR. Use of topical silver compound-containing agents for the treatment of patients with pyoderma. Vestnik Dermatologii i Venerologii, 2014, 1: 75-80.

38. Бакулев А.Л., Кравченя С.С., Платонова А.Н. Микробная экзема: современные возможности топической терапии с использованием сульфатиазола серебра. Вестник дерматологии и венерологии, 2015, 1: 111-121. /Bakulev AL, Kravchenya SS, Platonova AN. Microbial eczema: modern potential of topical therapy with sulfathiazole silver. Vestnik Dermatologii i Venerologii, 2015, 1: 111-121.

39. Зиновьев Е.В., Барташевич Е.В., Прохоренко А.В., Жарков А.В. Применение серебросодержащих кремов и раневого покрытия как пути улучшения системы местного лечения ран у пациентов с гнойно-некротическими формами синдрома диабетической стопы. Вестник Новгородского государственного университета, 2010, 59: 42-48. /Zinoviev EV, Bartashevich EV, Prokhorenko AV, Zharkov AV. Use of silver-containing creams and wound dressing as methods for improving thelocal treatment of wounds in patients with purulent-necrotic forms of diabetic foot syndrome. Vestnik Novgorodskogo Gosudarstvennogo Universiteta, 2010, 59: 42-48.


Для цитирования:


Родин А.В., Привольнев В.В., Барсуков А.Н. Возможности применения сульфатиазола серебра для местного лечения раневой инфекции. Стационарозамещающие технологии: Амбулаторная хирургия. 2018;(1-2):42-51. https://doi.org/10.21518/1995-14772018-1-2-42-51

For citation:


Rodin A.V., Privolnev V.V., Barsukov A.N. Therapeutic potential of sulfathiazole silver for topical treatment of wound infection. Ambulatory surgery: hospital-replacing technologies. 2018;(1-2):42-51. (In Russ.) https://doi.org/10.21518/1995-14772018-1-2-42-51

Просмотров: 158


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1995-1477 (Print)
ISSN 2658-3542 (Online)